Corvus Pharmaceuticals Inc (CRVS)
9.07
+0.13
(+1.45%)
USD |
NASDAQ |
Nov 22, 13:13
Corvus Pharmaceuticals Total Liabilities (Quarterly): 46.41M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 46.41M |
June 30, 2024 | 13.34M |
March 31, 2024 | 6.72M |
December 31, 2023 | 6.869M |
September 30, 2023 | 7.653M |
June 30, 2023 | 8.558M |
March 31, 2023 | 9.33M |
December 31, 2022 | 12.12M |
September 30, 2022 | 15.67M |
June 30, 2022 | 12.16M |
March 31, 2022 | 11.57M |
December 31, 2021 | 12.29M |
September 30, 2021 | 14.18M |
June 30, 2021 | 12.99M |
March 31, 2021 | 14.85M |
December 31, 2020 | 13.38M |
September 30, 2020 | 13.51M |
June 30, 2020 | 13.34M |
March 31, 2020 | 13.76M |
Date | Value |
---|---|
December 31, 2019 | 12.54M |
September 30, 2019 | 12.06M |
June 30, 2019 | 13.46M |
March 31, 2019 | 11.61M |
December 31, 2018 | 7.896M |
September 30, 2018 | 8.375M |
June 30, 2018 | 10.52M |
March 31, 2018 | 11.46M |
December 31, 2017 | 9.94M |
September 30, 2017 | 11.05M |
June 30, 2017 | 10.70M |
March 31, 2017 | 8.876M |
December 31, 2016 | 7.349M |
September 30, 2016 | 6.853M |
June 30, 2016 | 4.953M |
March 31, 2016 | 4.674M |
December 31, 2015 | 129.56M |
September 30, 2015 | 126.94M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.72M
Minimum
Mar 2024
46.41M
Maximum
Sep 2024
13.56M
Average
12.76M
Median
Total Liabilities (Quarterly) Benchmarks
Azenta Inc | 331.07M |
Perspective Therapeutics Inc | 62.68M |
Atara Biotherapeutics Inc | 233.24M |
Clearside Biomedical Inc | 63.95M |
Quanterix Corp | 74.54M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 58.82M |
Shareholders Equity (Quarterly) | 12.41M |